Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Ian F. Tannock, Ronald de Wit, William R. Berry, J Horti, A Płużańska, Kim N., Stéphane Oudard, Christine Théodore, Nicholas D. James, Ingela Turesson, Mark Rosenthal, Mario A. Eisenberger

New England Journal of Medicine, 2004

University of Toronto, Princess Margaret Cancer Centre, National Institute of Oncology, Medical University of Lodz, BC Cancer Agency, Hôpital Européen Georges-Pompidou, Hôpital Européen, Institut Gustave Roussy, Cancer Research UK, Uppsala University Hospital, Cancer Trials Australia, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University

Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

5702

Citations

View on Google Scholar

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Abstract

Journal Details

Join JournalsHub

Welcome Back